Figure 2.
Meta-analysis of incidence of Ki67 overexpression among NIH subgroups: (A) NIH VL group versus NIH L group; (B) NIH L group versus NIH I group; (C) NIH I group versus NIH H group. H = high risk, I = intermediate risk, L = low risk, NIH = National Institutes of Health, VL = very low risk.